Evolving strategies for preserving the pulmonary valve … · 2014-02-19 · Evolving strategies...
Transcript of Evolving strategies for preserving the pulmonary valve … · 2014-02-19 · Evolving strategies...
Evolving strategies for preserving the pulmonary valve during early repair of tetralogy
of Fallot: mid-term results
Alvise Guariento, MD
Pediatric and Congenital Cardiac Surgery Unit University of Padua Medical School
Background
Tetralogy of Fallot (TOF) repair has become nowadays a
standard routine practice
Al Habib HF, Jacobs JP, Mavroudis C, et al. Contemporary patterns of management of tetralogy ofFallot: data from theSociety of Thoracic Surgeons Database. Ann Thorac Surg. 2010 Sep;90(3):813-9.
Sarris GEE, Comas JV, Tobota Z, et al. Results of reparative surgery for tetralogy of Fallot: data from the European Association for Cardio-Thoracic Surgery Congenital Database. Eur J Cardiothorac Surg. 2012 Nov;42(5):766-74.
Stellin G, Milanesi O, Rubino M et al. Repair of tetralogy of Fallot in the first six months of life: transatrial versus transventricular approach. Ann Thorac Surg 1995;60:588–S591.
Correction via a right ventriculotomy
with RVOT TAP reconstruction remains
themost frequent approach
Many institutions have adopted, since many
years, atrans-atrial approach (TA) which
has become with time their preferred
standard procedure
• Commonly in any technique, when the use ofTAP is necessary
- PVR with chronic volume overload
- Progressive RV dilation and dysfunction
- Impaired functional capacity
Background
Development of different
PV preservation
techniques
Surgical history of repair (University of Padua)Evolution of our surgical policy
• Since 80’s: “Classic” transventricular
repair in infants
• Since 1991: Early transatrial one-stage
repair (6 3 months of age)
• Since 2007: Further evolution: PV
preservation
Our PV preservation technique
(since 2007 in selected patients)
• Intra-operative PV balloon dilatation during TA TOF repair
• Initial indication: less severe forms (PV Z score≥ -3)*
• Current indication: PV Z-score ≥ - 4**
* Vida VL, Padalino MA, Maschietto N, Biffanti R, Anderson RH, Milanesi O, Stellin G. The balloon dilation of the pulmonary valveduring early repair of Tetralogy of Fallot. Catheter Cardiovasc Interv. 2012 Nov 15;80(6):915-21.
** Vida VL, Guariento A, Castaldi B, Sambugaro M, Padalino MA, Milanesi O, Stellin G Evolving strategies for preserving thepulmonary valve during early repair of tetralogy of Fallot: mid-term results. Jour ThoracCardiovasc Surg 2013 (IN PRESS)
PV Z-score: -3.6
4 mm6 mm
10 mm
At 2D: 5.5 mm
Z-score= -3.6
8- 10 mm
“In-series” PV balloon dilatation
Additional PV plasty
Additional PV plasty after balloon dilation
* “De-lamination” : to increase the PV leaflet’s coaptation surface
1) PV leaflets repair 2) PV leaflets “de-lamination” *3) PV leaflets re-suspension
PV plasty:
Aim of the study
To assesseffectiveness, early and mid-termresults of the PVpreservation technique by balloon dilation in pts with TOFmainly focusing on:
1) PV function and growth2) RV function
Controls: patients treated with a standard TA repair (with TAP) during thesame time interval
PatientsJune 2007 – December 2012
69 PATIENTS
+
Reason for PV preservation failure:
1) tearing of the hinges of the PV leaflets due to over-sizing of theballoon catheter(n=3)(early in our experience)
2) very low PV Z-score (<-4)(n=2).
5 Conversions to TA repair
34 PV preservation success (49%)
30Control TA repair
39 PV preservation attempts
- PTFE cusp (n=23)- CorMatrix cusp (n=10)
- Autologous pericardium cusp (n=1)- Pulmonaty homograft cusp (n=1)
Preoperative variables and results
PV dilation group(n=34)
Control TA group(n=35)
p value
Age at surgery, days (range) 115 (36-521) 113 (65-454) 0.41Median PV annulus at 2D, mm (range) 6.8 (5.5-8.8) 6 (4-9.5) 0.02Median PV Z-score on 2D, n (%) -2.95 (-0.95 - -4.06) -3.35 (-1.54 - -5.62) 0.03Coronary artery anomalies, n (%) 1 (2.9%) 4 (11.4%) 0.36Median preop trans-cut. O2 sat, n (%) 94 (80-100) 90 (80-100) 0.03Median preop RVOT grad, mmHg (range) 67 (40-87) 70 (55-93) 0.12Median CPB time, min (range) 125 (93-200) 158 (104-237) 0.0001Median CCT, min (range) 76 (45-118) 75 (48-114) 0.93
RVP/SBP after CPB discontinuation- ≤ 1/3- ≤ 1/2- ≤ ¾
8 (23.5%)19 (55.9%)7 (20.6%)
10 (28.6%)21 (60%)4 (11.4%)
0.56
ICU complications, n (%) 11 (32.4%) 8 (22.9%) 0.54
Postop temporary junc.tachycardia, n (%) 6 (17.6%) 1 (2.9%) 0.04Postop. LOS, n (%) 3 (8.8%) 3 (8.6%) 0.99Median ICU stay, days (range) 3 (1-8) 3 (1-12) 0.46Median hospitalization, days (range) 10 (7-43) 10.5 (7-31) 0.7
Echocardiographic evaluation at discharge
PV dilation group(n=34)
Standars TA group(n=35)
p value
Degree of TR, n (%)
•Grade 1 (mild)•Grade 2 (moderate)•Grade 3 (severe)
30 (91.2%)3 (8.8%)
-
33 (94.3%)2 (5.7%)
-0.48
Median RVOT gradient, mmHg (range) 29 (18 – 50) 25 (12 – 50) 0.18
RVOT gradient grade, n (%)
•Grade 1 (<20 mmHg)•Grade 2 (20 – 40 mmHg)•Grade 3 (>40 mmHg)
1 (2.9%)30 (88.2%)3 (8.8%)
7 (20%)26 (77.1%)1 (2.9%)
0.07
Degree of PVR*, n (%)
•Grade 1 (none-mild)•Grade 2 (moderate)•Grade 3 (severe)
30 (88.2%)4 (11.8%)
-
14 (40%)9 (25.7%)12 (34.3%)
0.0001
* Grothoff M, Spors B, Abdul-Khaliq H, Gutberlet M: Evaluation of postoperative pulmonary regurgitation after surgical repair of tetralogy of Fallot: Comparison between doppler echocardiography and mr velocity mapping. Pediatr Radiol. 2008; 38: 186-191
Follow-up
PV dilation group(n=34)
Standars TA group(n=35)
p value
Follow-up time, days (range) 432 (189 – 1940) 711 (189 – 1492) 0.08
Reoperations, n (%) 1* (2.9%) 1** (2.8%) 0.9
Both with a residual peak RVOT gradient > 50 mmHg
Both required additional RVOT muscle bandle resection, TAP + PTFE PV cusp interposition
Echocardiographic evaluation at follow-up(pts with FU >6 months)
PV dilation group(n=30)
Standars TA group(n=32)
p value
Degree of TR, n (%)
•Grade 1 (mild)•Grade 2 (moderate)•Grade 3 (severe)
30 (100%)--
32 (100%)--
0.99
Median RVOT gradient, mmHg (range) 23.5 (8 – 40) 22 (7 – 45) 0.85
RVOT gradient grade, n (%)
•Grade 1 (<20 mmHg)•Grade 2 (20 – 40 mmHg)•Grade 3 (>40 mmHg)
18 (60%)12 (40%)
-
18 (56%)12 (38%)2 (6%)
0.37
•PV Z-score, n (range) -0.1 (-0.3 - +0.7) - -
Degree of PVR, n (%)
•Grade 1 (none-mild)•Grade 2 (moderate)•Grade 3 (severe)
24 (80%)6 (20%)
-
8 (25%)11 (35%)13 (40%)
<0.0001
(p-value 0,018)
Echocardiographic evaluation (at discharge)
NEW DILATATION TECHNIQUE
Grade 1: MILD
Grade 2: MODERATE
Grade 3: SEVERE
«CLASSIC» TAP TECHNIQUE
Pulmonary insufficiency
(p-value < 0,0001)
Echocardiographic evaluation (at follow-up)
NEW DILATATION TECHNIQUE
Grade 1: MILD
Grade 2: MODERATE
Grade 3: SEVERE
«CLASSIC» TAP TECHNIQUE
Pulmonary insufficiencyFOLLOW-UP:
432 days(range 189 – 1940)
(p-value < 0,0001)
p=0.00355% (42-70) 50% (40-63)
PV dilatation group Standard TA group
Echocardiographic evaluation at follow-upRV fraction of area change
Horton KD, Meece RW, Hill JC: Assessment of the right ventricle by echocardiography: A primer for cardiac sonographers. J Am Soc Echocardiogr. 2009; 22: 776-792.
Anavekar NS, Gerson D, Skali H, Kwong RY, Yucel EK, Solomon SD: Twodimensional assessment of right ventricular function: An echocardiographic-mri correlative study. Echocardiography. 2007; 24: 452-456.
Limitations
- Retrospective evaluation
- Mid-termfollow-up
- RV function assessment by 2D echo
- Still on a learning curve phase
Conclusions
• PV function can be preservedby balloon
dilatation during early TOF repair.
• Middle term results of valve-sparing
techniques are encouraging.
Conclusions
Preservation of PVanatomical and functional integrity, together
with a transatrial/transpulmonary early repair, seems to be an
encouraging approach for better preserving the:
RIGHT VENTRICULAR FUNCTION
IN THE LONG TERM
THANKS FOR YOUR ATTENTION
Anatomical Theatre – Palazzo Bo - Padova Galileo Galilei’s chair– Palazzo Bo - Padova
PV anatomy
PV dilation group(n=34)
Standars TA group(n=35)
p value
Unicuspid (n=4 pts) - 4 (100%)
0.001Bicuspid (n=59 pts) 28 (47.4%) 30 (52.6%)
Tricuspid (n=6 pts) 6 (100%) -
Median preoperative PV Z-score p value
Unicuspid (n=4 pts) -4.26 (-2.97 - -4.98)
0.0004Bicuspid (n=59pts) -3.2 (-0.95 - -5.62)
Tricuspid (n=6 pts) -1.73 (-1.19 - -2.44)
“In -series” PV balloon dilationn=15 / 35 patients (44%)
PV Z-score -2.29 (-0.95 - -3.74) -3.56 (-2.28 - -4.06)
Single BD n=20 pts
“In-series” BD n= 15 pts
p=0.002
Simple PV plastyn=4 pts
Additional PV plasty after balloon dilation (n=18 pts, 53%)
Complex PV plastyn=14 pts
PV Z-score -2.34 (-1.52 - -2.78) -3.5 (-2.28 - -4.06)
p=0.01
E-E2)(PV Z-score -3 - -3.5)PV leaflet’s de-laminationand re-suspension plasty
Our current PV preservationsurgical protocol
A-C) common pathway including“protective” commissurotomy andballoon dilation of the pulmonary valveannulus.
D-D1)(PV Z-score≥ -3)Additional PV plasty, forrepairing accidental leaflet’stears during balloon dilation,and leaflet’s re-suspension.
F)(PV Z-score -3.5 - -4)Additional PV leaflets’spatch augmentation andre-suspension plasty.